1 Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China 2 Department of Biomedical Sciences Laboratory, Affiliated Dongyang Hospital of Wenzhou ...

1 Department of Obstetrics and Gynaecology, School of Clinical Medicine, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China 2 Shenzhen Key Laboratory ...

which probably derive from naive B cells expressing CD5. This tumour is considered one of the most aggressive lymphoid neoplasms, with poor responses to conventional chemotherapy and relatively ...

2024 — The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5 ...

Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern Medicine study recently published in the Journal of Clinical Investigation.

Oct. 9, 2024 — Researchers have developed a groundbreaking cell culture platform that enables the formation of two distinct but interconnected vascular networks. Their breakthrough holds ...

Diffuse large B cell lymphoma (DLBCL) is a cancer that affects white blood cells called B cell lymphocytes. Ordinarily, these cells help protect against infection and disease. In DLBCL ...

The adrenal CT scan showed a left adrenal mass crossing to the midline to affect the right adrenal gland and the core biopsy of the right adrenal mass confirmed diffuse large B-cell lymphoma. Flow ...

T cells and B-1 cells express CD5, a scavenger receptor family member that is associated with antigen receptors. A few recent studies have characterized the binding of β-glucan to CD5 on T cells and B ...

We compared obinutuzumab, a humanised type II anti-CD20 monoclonal antibody that induces potent B-cell depletion, with placebo for the treatment of LN in combination with standard therapies. Methods ...